Substances · Phenethylamine derivatives
4-FMA
- Preferred name
- 4-FMA
- IUPAC name
- 1-(4-fluorophenyl)-N-methylpropan-2-amine
- Parent CAS number (reference)
- 52063-62-4
- Molecular formula
- C10H14FN
- Molecular weight
- 167.22 g/mol
- InChIKey
- YCWZPIHKUYZTFM-UHFFFAOYSA-N
- PubChem
- CID 11745017
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
4-Fluoromethamphetamine 4FMA 4 FMA
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
4-FMA
Receptor Telemetry & Mechanism of Action
4-FMA is the para-fluoro analogue of methamphetamine. Para-fluorination, as with 4-FA, shifts the releaser profile toward serotonin as well as dopamine and norepinephrine, so the subjective feel is more entactogenic than 2-FMA. The same para-fluoro pattern is the one associated with cardiotoxicity and hemorrhagic stroke in the 4-FA literature. 4-FMA should be treated as sharing that concern, not as a harmless longer 2-FMA.
Biotransformation & Active Metabolites
Likely N-demethylates toward 4-FA. That does not make the oral charts identical: PsychonautWiki places 4-FMA common at 50–100 mg and 4-FA common at 100–130 mg, with different durations.
Temporal Pharmacokinetics
Entactogenic stimulant: warmth and sociability laid over a long catecholamine push, with a harder cardiovascular reputation than 2-FMA.
- Onset 20–40 minutes
- Peak Window 2–5 hours
- Total Window 4–8 hours
- Residual / Half-Life After-effects 3–12 hours of insomnia, low mood, and residual stimulation. Human half-life is not established.
Threshold 10 mg, light 25–50 mg, common 50–100 mg, strong 100–125 mg, heavy above 125 mg. Strong and heavy are only 25 mg apart. A severe headache on 4-fluoroamphetamine compounds is a reason to seek emergency care, by analogy with the 4-FA stroke reports, not a reason to take a painkiller and continue.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
10 mg
Light mood lift and wakefulness.
Small pulse increase.
25–50 mg
Mild sociability and stimulation without a full entactogenic wave.
Appetite loss, dry mouth, and jaw awareness.
50–100 mg
Warm mood elevation, talkativeness, and music enhancement alongside clear stimulation.
Tachycardia, sweating, bruxism, dilated pupils, and vasoconstriction.
100–125 mg
Intense entactogenic stimulation, scattered thought, and irritability as the serotonin tone peaks.
Marked hypertension, hyperthermia risk, and a headache that must not be ignored.
125 mg+
Agitation, confusion, and a toxic stimulant state rather than 'more empathy'.
Chest pain, severe headache, possible cerebrovascular symptoms, seizures with tramadol, and serotonin toxicity if another releaser is present.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.
Stacked serotonin release is a serotonin-syndrome pattern, with hyperthermia and seizures.
Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.
Elevated Hazard — Avoid
Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.
The stimulant hides sedation. When it drops, the depressant remains.
Seizure threshold plus serotonin reuptake inhibition on a serotonergic releaser.
Caution / Receptor Attenuation
Often increases heart rate and paranoid thought on the offset.
Blunt the serotonergic portion of entactogen-type members while the cardiovascular load stays. They are not protection against serotonin toxicity.
Structural Isomer & Sibling Comparison
4-FMA shares the formula C10H14FN and the mass 167.22 g/mol with 2-FMA but not the dose or the feel. 2-FMA common is 15–30 mg of a flat functional stimulant. 4-FMA common is 50–100 mg and warmer. 4-FA is the primary amine, common 100–130 mg, with a published stroke signal and an even tighter strong band (130–150 mg). Treating them as one 'fluoro' powder is how those numbers get swapped.
Physicochemical Stability & Storage
Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.
Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.
Cross-Tolerance & Dependence Profile
Stimulant tolerance and serotonergic depletion both apply. Acute tolerance halves over several days to two weeks. Cross-tolerance with amphetamines and with MDMA-like releasers. Repeating entactogenic doses in the same week mainly increases cardiovascular load and worsens the crash.
Chemical Architecture & Structural Profile
4-FMA (1-(4-fluorophenyl)-N-methylpropan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C10H14FN and a molar mass of 167.22 g/mol. The parent molecule is indexed under CAS registry number 52063-62-4 and in the NCBI PubChem database as CID 11745017 (Standard InChIKey: YCWZPIHKUYZTFM-UHFFFAOYSA-N). This molecule shares its empirical formula (C10H14FN) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (52063-62-4), and spectroscopic profile.
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 4-FMA is indexed within the Substituted amphetamines structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- EUDA / National Chemical & Controlled Substance Registry (IE) — National Regulatory Authority (IE) (2026-11-12)